UpToDate® : Oncology Times
An abstract is unavailable.
An abstract is unavailable.
AbstractBackground. Brain metastasis invasion pattern (BMIP) is an emerging biomarker associated with recurrence-free and overall survival in patients, and
On January 16, 2025, the FDA granted traditional approval to acalabrutinib (Calquence, AstraZeneca) with bendamustine and rituximab for adults with previously untreated mantle cell lymphoma…
Researchers noted that the safety and effectiveness of standard therapies for Merkel cell carcinoma “remains poorly studied.”
EZH2 inhibitors dramatically enhance the effects of RAS pathway inhibitors by cooperatively suppressing the WNT pathway, thereby driving differentiation and enhancing apoptosis and tumor regression…
An abstract is unavailable.
rtebral bodies (3d-VBs). Background. Postoperative subsidence of TMCs in ACCF has been widely reported. Newer implants such as n-HA/PA66 cages and 3d-VBs using biocompatible titanium…
This article describes the outcomes of patients who were treated with tivozanib for advanced renal cell carcinoma (RCC) and provides data to guide sequenci
Nicolas Girard, MD, compares the predictive value, mechanisms of action, and safety or efficacy profile of HER2-targeted TKIs vs ADCs in NSCLC.
CD74 signaling drives inflammation and differentiation defects in hematopoietic stem and progenitor cells in RUNX1-familial platelet disorder.
r-old man underwent bilateral phakic IOL implantation for high myopia in the context of a borderline cornea, characterized by keratometric asymmetry and anterior elevation at…